|
![]() |
|||
|
||||
OverviewThe world's leading experts provide all the 'essentials' needed to manage HIV patients in the office, on the ward, and in the ICU. HIV Essentials incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs. The Ninth Edition features updates to content and numerous tables to reflect the latest DHHS guidelines and the 2020 IAS-USA guidelines for HIV treatment. Full Product DetailsAuthor: Paul E. Sax , Melanie BerryPublisher: Jones and Bartlett Publishers, Inc Imprint: Jones and Bartlett Publishers, Inc Edition: 9th edition Weight: 0.113kg ISBN: 9781284223668ISBN 10: 1284223663 Pages: 300 Publication Date: 15 November 2021 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: To order ![]() Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us. Table of ContentsReviewsAuthor InformationDr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women’s Hospital (BWH), where he holds the Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases, and Professor of Medicine at Harvard Medical School. Dr. Sax received his MD from Harvard Medical School, completed his residency in Internal Medicine at BWH, then fellowship in Infectious Diseases at Massachusetts General Hospital. He is Editor-in-Chief of Clinical Infectious Diseases, the flagship journal of the Infectious Diseases Society of America, and is Section Editor of HIV/AIDS in UpToDate. He writes HIV and ID Observations for NEJM Journal Watch, and is on the Antiretroviral Guidelines Panel of the International Antiviral Society – USA. Dr. Sax teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice, writing, and teaching, his ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. Melanie Berry, PharmD, BCACP, AAHIVP, is a Clinical Pharmacy Specialist at Boston Medical Center (BMC). Dr. Berry graduated with her Doctorate in Pharmacy from University of Missouri-Kansas City School of Pharmacy. She completed a PGY1 residency in Community Pharmacy at Cleveland Clinic and a PGY2 residency in Ambulatory Care at Boston Medical Center. She is a board certified Ambulatory Care pharmacist and credentialed HIV Pharmacist through the American Academy of HIV Medicine. Dr. Berry’s focus is in HIV and Pre-Exposure Prophylaxis (PrEP). She practices in the Center for Infectious Diseases and Sexual Health Clinics at Boston Medical Center. Tab Content 6Author Website:Countries AvailableAll regions |